Australia provisionally approves Moderna’s COVID shot for children aged below five years

So far, the shot was provisionally approved in the country for individuals aged six years and older and as a booster dose for those aged 18 years and older, TGA said

Moderna said recently Australia’s drug regulator Therapeutic Goods Administration (TGA) has provisionally approved its mRNA COVID-19 vaccine, Spikevax, for use in children aged six months to five years.

So far, the shot was provisionally approved in the country for individuals aged six years and older and as a booster dose for those aged 18 years and older, TGA said in a separate statement.

The move comes as Australia battles a major virus outbreak fuelled by the highly transmissible new Omicron subvariants, BA.4 and BA.5, with hospital admissions surpassing record levels in several states.

Last week, Argentina and Canada also approved Moderna’s COVID-19 vaccine for kids aged six months to five years.

PHARMALEADERS

Pharmaleaders is India’s first opinion based & research driven bi-monthly magazine & has a decade of relentless reporting in Pharma Journalism in an unbiased, fearless & independent way. Over the last one decade, The Magazine has covered some of the biggest voices in the healthcare Industry. Available both in digital & printed format, Pharmaleaders has emerged out as a leading title in voicing the opinion of the healthcare industry.